Sun Pharmaceutical Industries’ US-based arm recalls generic drug in US market

24 Apr 2023 Evaluate

Sun Pharmaceutical Industries’ US-based arm -- Sun Pharmaceutical Inc is recalling 16,450 vials of Norepinephrine Bitartrate Injection for ‘Failed Impurities/Degradation Specifications’. The company is recalling a generic drug indicated to raise blood pressure in adult patients with acute hypotension. The affected lot has been manufactured by Hyderabad-based Gland Pharma and distributed in the US by Sun Pharmaceutical Industries. Sun Pharmaceutical Inc initiated the Class III nationwide recall (US) on March 29 this year.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1669.20 -31.35 (-1.84%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×